Ziv-Aflibercept in Treating and Computed Tomography Perfusion Imaging in Predicting Response in Patients With Pancreatic Neuroendocrine Tumors That Are Metastatic or Cannot Be Removed by Surgery
Clinical trial NCT02101918 · COMPLETED
Trial details
- NCT number
- NCT02101918
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-18
- Primary completion
- 2018-01-31
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.